Microbiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Microbiology 142 (1996), 1369-1374
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sjostedt, A.
Right arrow Articles by Conlan, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sjostedt, A.
Right arrow Articles by Conlan, J. W.
Agricola
Right arrow Articles by Sjostedt, A.
Right arrow Articles by Conlan, J. W.

microbiology, Vol 142, 1369-1374, Copyright © 1996 by Society for General Microbiology


ARTICLES

The requirement of tumour necrosis factor-alpha and interferon-gamma for the expression of protective immunity to secondary murine tularaemia depends on the size of the challenge inoculum

A Sjostedt, RJ North and JW Conlan
Trudeau Institute, Inc., Saranac Lake, NY 12983, USA. sjostedt@ume.foa.se

The present study was conducted to determine the extent to which the cytokines tumour necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) are required to protect against primary or secondary murine tularaemia caused by the live vaccine strain of the facultative intracellular bacterium Francisella tularensis. It is shown that non- immune mice treated with neutralizing monoclonal antibodies (mAbs) against TNF-alpha and IFN-gamma are rendered defenceless against otherwise sublethal intravenous inocula of the bacterium. Treatment with either of the anti-cytokine mAbs resulted in even a very small inoculum of 500 c.f.u. of the pathogen multiplying unrestrictedly in the livers, spleens and lungs of non-immune mice to rapidly reach lethal numbers. By contrast, Francisella-immune mice treated with either of the mAbs remained capable of resolving secondary infection with 50-fold larger inocula. However, the need for TNF-alpha and IFN- gamma for controlling secondary tularaemia became critical when challenge inocula exceeded 10(6) c.f.u. Overall, the results imply that different defence mechanisms operate to control primary versus secondary murine tularaemia. Additionally, they show that the need for TNF-alpha and IFN-gamma to combat secondary infection depends on the size of the challenge inoculum.


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
J. M. Ketavarapu, A. R. Rodriguez, J.-J. Yu, Y. Cong, A. K. Murthy, T. G. Forsthuber, M. N. Guentzel, K. E. Klose, M. T. Berton, and B. P. Arulanandam
Mast cells inhibit intramacrophage Francisella tularensis replication via contact and secreted products including IL-4
PNAS, July 8, 2008; 105(27): 9313 - 9318.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. D. Woolard, L. L. Hensley, T. H. Kawula, and J. A. Frelinger
Respiratory Francisella tularensis Live Vaccine Strain Infection Induces Th17 Cells and Prostaglandin E2, Which Inhibits Generation of Gamma Interferon-Positive T Cells
Infect. Immun., June 1, 2008; 76(6): 2651 - 2659.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Lembo, M. Pelletier, R. Iyer, M. Timko, J. C. Dudda, T. E. West, C. B. Wilson, A. M. Hajjar, and S. J. Skerrett
Administration of a Synthetic TLR4 Agonist Protects Mice from Pneumonic Tularemia
J. Immunol., June 1, 2008; 180(11): 7574 - 7581.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. C. Cowley, J. D. Sedgwick, and K. L. Elkins
Differential Requirements by CD4+ and CD8+ T Cells for Soluble and Membrane TNF in Control of Francisella tularensis Live Vaccine Strain Intramacrophage Growth
J. Immunol., December 1, 2007; 179(11): 7709 - 7719.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. S. Kirimanjeswara, J. M. Golden, C. S. Bakshi, and D. W. Metzger
Prophylactic and Therapeutic Use of Antibodies for Protection against Respiratory Infection with Francisella tularensis
J. Immunol., July 1, 2007; 179(1): 532 - 539.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
R. KuoLee, X. Zhao, J. Austin, G. Harris, J. W. Conlan, and W. Chen
Mouse Model of Oral Infection with Virulent Type A Francisella tularensis
Infect. Immun., April 1, 2007; 75(4): 1651 - 1660.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
H. Lindgren, H. Shen, C. Zingmark, I. Golovliov, W. Conlan, and A. Sjostedt
Resistance of Francisella tularensis Strains against Reactive Nitrogen and Oxygen Species with Special Reference to the Role of KatG
Infect. Immun., March 1, 2007; 75(3): 1303 - 1309.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. H. Barker, J. Weiss, M. A. Apicella, and W. M. Nauseef
Basis for the Failure of Francisella tularensis Lipopolysaccharide To Prime Human Polymorphonuclear Leukocytes.
Infect. Immun., June 1, 2006; 74(6): 3277 - 3284.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. A. Pammit, E. K. Raulie, C. M. Lauriano, K. E. Klose, and B. P. Arulanandam
Intranasal Vaccination with a Defined Attenuated Francisella novicida Strain Induces Gamma Interferon-Dependent Antibody-Mediated Protection against Tularemia
Infect. Immun., April 1, 2006; 74(4): 2063 - 2071.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
N. S. Duckett, S. Olmos, D. M. Durrant, and D. W. Metzger
Intranasal Interleukin-12 Treatment for Protection against Respiratory Infection with the Francisella tularensis Live Vaccine Strain
Infect. Immun., April 1, 2005; 73(4): 2306 - 2311.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
H. Lindgren, S. Stenmark, W. Chen, A. Tarnvik, and A. Sjostedt
Distinct Roles of Reactive Nitrogen and Oxygen Species To Control Infection with the Facultative Intracellular Bacterium Francisella tularensis
Infect. Immun., December 1, 2004; 72(12): 7172 - 7182.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
H. Lindgren, I. Golovliov, V. Baranov, R. K. Ernst, M. Telepnev, and A. Sjostedt
Factors affecting the escape of Francisella tularensis from the phagolysosome
J. Med. Microbiol., October 1, 2004; 53(10): 953 - 958.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
S. Stenmark and A. Sjostedt
Transfer of specific antibodies results in increased expression of TNF-{alpha} and IL12 and recruitment of neutrophils to the site of a cutaneous Francisella tularensis infection
J. Med. Microbiol., June 1, 2004; 53(6): 501 - 504.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
S. C. Cowley and K. L. Elkins
Multiple T Cell Subsets Control Francisella tularensis LVS Intracellular Growth Without Stimulation Through Macrophage Interferon {gamma} Receptors
J. Exp. Med., August 4, 2003; 198(3): 379 - 389.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
K. L. Elkins, A. Cooper, S. M. Colombini, S. C. Cowley, and T. L. Kieffer
In Vivo Clearance of an Intracellular Bacterium, Francisella tularensis LVS, Is Dependent on the p40 Subunit of Interleukin-12 (IL-12) but Not on IL-12 p70
Infect. Immun., April 1, 2002; 70(4): 1936 - 1948.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. M. Bosio and K. L. Elkins
Susceptibility to Secondary Francisella tularensis Live Vaccine Strain Infection in B-Cell-Deficient Mice Is Associated with Neutrophilia but Not with Defects in Specific T-Cell-Mediated Immunity
Infect. Immun., January 1, 2001; 69(1): 194 - 203.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. Stenmark, D. Sunnemark, A. Bucht, and A. Sjostedt
Rapid Local Expression of Interleukin-12, Tumor Necrosis Factor Alpha, and Gamma Interferon after Cutaneous Francisella tularensis Infection in Tularemia-Immune Mice
Infect. Immun., April 1, 1999; 67(4): 1789 - 1797.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1996 Society for General Microbiology.